keyword
https://read.qxmd.com/read/38656400/thrombus-or-tumor-a-case-report-of-a-rare-sarcoma-entity-intimal-sarcoma-of-the-pulmonary-arteries
#1
JOURNAL ARTICLE
A Dörr, A Flörcken, L Bullinger, D Capper, A Von Deimling, D Kaul, S Märdian, C Starck, D Horst, M P Dragomir, F M Schäfer, A Jarosch
BACKGROUND: Tumor embolism is a very rare primary manifestation of cancers and the diagnosis is challenging, especially if located in the pulmonary arteries, where it can mimic nonmalignant pulmonary embolism. Intimal sarcoma is one of the least commonly reported primary tumors of vessels with only a few cases reported worldwide. A typical location of this malignancy is the pulmonary artery. Herein, we present a case report of an intimal sarcoma with primary manifestation in the pulmonary arteries...
April 24, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38654461/thrombosis-risk-prediction-in-lymphoma-patients-a-multi-institutional-retrospective-model-development-and-validation-study
#2
JOURNAL ARTICLE
Shengling Ma, Jennifer La, Kaitlin N Swinnerton, Danielle Guffey, Raka Bandyo, Giordana De Las Pozas, Katy Hanzelka, Xiangjun Xiao, Cristhiam M Rojas-Hernandez, Christopher I Amos, Vipul Chitalia, Katya Ravid, Kelly W Merriman, Christopher R Flowers, Nathanael Fillmore, Ang Li
Venous thromboembolism (VTE) poses a significant risk to cancer patients receiving systemic therapy. The generalizability of pan-cancer models to lymphomas is limited. Currently, there are no reliable risk prediction models for thrombosis in patients with lymphoma. Our objective was to create a risk assessment model (RAM) specifically for lymphomas. We performed a retrospective cohort study to develop Fine and Gray sub-distribution hazard model for VTE and pulmonary embolism (PE)/ lower extremity deep vein thrombosis (LE-DVT) respectively in adult lymphoma patients from the Veterans Affairs national healthcare system (VA)...
April 23, 2024: American Journal of Hematology
https://read.qxmd.com/read/38651102/case-report-association-between-pten-gene-variant-and-an-aggressive-case-of-multiple-davfs
#3
Glaucia Suzanna Jong-A-Liem, Talita Helena Martins Sarti, Mariusi Glasenapp Dos Santos, Luciano Marcus Tirotti Giacon, Raphael Wuo-Silva, Alex Machado Baeta, José Maria de Campos Filho, Feres Chaddad-Neto
INTRODUCTION: Mutations of the phosphatase and tensin homolog (PTEN) gene have been associated with a spectrum of disorders called PTEN hamartoma tumor syndrome, which predisposes the individual to develop various types of tumors and vascular anomalies. Its phenotypic spectrum includes Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), Proteus syndrome, autism spectrum disorders (ASD), some sporadic cancers, Lhermitte-Duclos disease (LDD), and various types of associated vascular anomalies...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38650055/edoxaban-for-12-versus-3-months-in-cancer-associated-isolated-distal-deep-vein-thrombosis-according-to-different-doses-insights-from-the-onco-dvt-study
#4
JOURNAL ARTICLE
Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Michihisa Umetsu, Yuji Nishimoto, Takuma Takada, Yoshito Ogihara, Tatsuya Nishikawa, Nobutaka Ikeda, Kazunori Otsui, Daisuke Sueta, Yukari Tsubata, Masaaki Shoji, Ayumi Shikama, Yutaka Hosoi, Yasuhiro Tanabe, Kengo Tsukahara, Naohiko Nakanishi, Kitae Kim, Satoshi Ikeda, Kazunori Mushiake, Kazushige Kadota, Koh Ono, Takeshi Kimura
BACKGROUND: The ONCO DVT study revealed the superiority of 12-month relative to 3-month edoxaban treatment for cancer-associated isolated distal deep vein thrombosis (DVT) regarding the thrombotic risk. METHODS: In this pre-specified subgroup analysis of the ONCO DVT study, we stratified the patients into those with a standard edoxaban dose (60 mg/day; N=151) and those with a reduced edoxaban dose (30 mg/day; N=450) and evaluated the clinical outcomes for the 12-month and 3-month treatments...
April 22, 2024: European Heart Journal. Cardiovascular Pharmacotherapy
https://read.qxmd.com/read/38649381/tspan-protein-family-focusing-on-the-occurrence-progression-and-treatment-of-cancer
#5
REVIEW
Huhu Zhang, Qinghang Song, Kaiwen Shang, Ya Li, Liangqian Jiang, Lina Yang
The Tetraspanins (Tspan) protein family, also known as the tetraspanin family, contains 33 family members that interact with other protein molecules such as integrins, adhesion molecules, and T cell receptors by forming dimers or heterodimers. The Tspan protein family regulates cell proliferation, cell cycle, invasion, migration, apoptosis, autophagy, tissue differentiation, and immune response. More and more studies have shown that Tspan proteins are involved in tumorigenesis, epithelial-mesenchymal transition, thrombosis, tumor stem cell, and exosome signaling...
April 22, 2024: Cell Death Discovery
https://read.qxmd.com/read/38644311/-a-long-surviving-case-of-locally-advanced-breast-cancer-with-multiple-lung-metastasis
#6
JOURNAL ARTICLE
Eigo Satoh, Yui Innami, Daisuke Uehira, Koji Yonekura, Ayano Murakata, Ryoki Ohinata, Yasuhiro Toyofuku, Hideaki Tanami, Takayuki Osanai, Norihide Sugano, Takaaki Sakoma
We report a case of right advanced breast cancer with multiple lung metastases in a 66-year-old woman. Her breast cancer( invasive ductal carcinoma, cT4bN1M1, Stage Ⅳ)was resected in October 2007(mastectomy plus axillary lymph node dissection)after local arterial infusion therapy(total dose 5-FU 4,735 mg plus adriamycin 180 mg), which caused bilateral lung arterial embolism due to deep vein thrombosis in right her leg. She had to be treated by anticoagulant therapy, mechanical ventilation and placement of IVC filter before her operation...
April 2024: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://read.qxmd.com/read/38643522/platelet-fc%C3%AE-riia-an-emerging-regulator-and-biomarker-in-cardiovascular-disease-and-cancer
#7
JOURNAL ARTICLE
Qingsong Zhang, Wenxian Li, Xin Mao, Shuo Miao
Platelets, anucleate blood cells derive from megakaryocytes, are involved in cardiovascular diseases and tumors. FcγRIIA, the only FcγR expressed on human platelets, is known for its role in immune-related diseases. A growing body of evidence reveals that platelet FcγRIIA is a potential target for the prevention and control of cardiovascular disease and cancer, and is an advantageous biomarker. In this review, we describe the structure and physiological function of platelet FcγRIIA, its regulatory role in cardiovascular disease and cancer, and its potential clinical application...
April 16, 2024: Thrombosis Research
https://read.qxmd.com/read/38643438/comparison-of-the-padua-and-improve-scores-in-assessing-venous-thromboembolism-risk-in-42-257-medical-inpatients-in-china
#8
JOURNAL ARTICLE
Hou Yifang, Duan Jun, Yan Jingting, Shan Ying, Zhang Ping, Deng Xiaomei
Venous thromboembolism (VTE) is a major contributor to hospital mortality and disability-adjusted life-year (DALY) loss. Multiple guidelines recommend using the Padua or IMPROVE scores to stratify VTE risk in hospitalized medical patients. However, the IMPROVE score is not recommended in Chinese guidelines, and there is very little evaluation of its clinical application and effectiveness in the Chinese population. The objective of this study is to compare the efficacy of the Padua and IMPROVE scoring models for assessing VTE risk in Chinese medical inpatients...
April 21, 2024: Journal of Thrombosis and Thrombolysis
https://read.qxmd.com/read/38643313/haemostatic-gene-variations-in-cervical-cancer-associated-venous-thrombosis-considerations-for-clinical-strategies
#9
JOURNAL ARTICLE
Beatriz Vieira Neto, Valéria Tavares, José Brito da Silva, Joana Liz-Pimenta, Inês Soares Marques, Lurdes Salgado, Luísa Carvalho, Deolinda Pereira, Rui Medeiros
Venous thromboembolism (VTE) is a life-threatening haemostatic disease frequently diagnosed among the cancer population. The Khorana Score is currently the primal risk assessment model to stratify oncological patients according to their susceptibility to VTE, however, it displays a limited performance. Meanwhile, intensive research on VTE pathophysiology in the general population has uncovered a range of single-nucleotide polymorphisms (SNPs) associated with the condition. Nonetheless, their predictive ability concerning cancer-associated thrombosis (CAT) is controversial...
April 20, 2024: Journal of Thrombosis and Thrombolysis
https://read.qxmd.com/read/38643312/primary-thromboprophylaxis-in-cancer-outpatients-real-world-evidence
#10
JOURNAL ARTICLE
Joana Liz-Pimenta, Valéria Tavares, João Gramaça, João Rato, Maria Menezes, Mafalda Baleiras, Helena Guedes, Joana Reis, Catarina Guedes, Rosa Gomes, Miguel Barbosa, Marta Sousa, Alok A Khorana, Rui Medeiros
INTRODUCTION: Cancer-associated thrombosis (CAT) is a significant concern among patients with malignant diseases, leading to increased mortality. While current guidelines recommend primary thromboprophylaxis for venous thromboembolism (VTE) in medium-to-high-risk outpatients, this practice remains controversial. A better understanding of primary thromboprophylaxis is crucial, yet there is a lack of Real-World Evidence (RWE) in Portugal. AIMS: This RWE study aimed to elucidate primary thromboprophylaxis practices among cancer outpatients in Portugal...
April 20, 2024: Journal of Thrombosis and Thrombolysis
https://read.qxmd.com/read/38643097/the-effects-of-different-positions-on-lower-extremity-hemodynamics-during-robot-assisted-laparoscopic-radical-prostatectomy-for-prostate-cancer
#11
JOURNAL ARTICLE
Zheng Wang, Xinyu Wang, Xiaofen Yu
PURPOSE: This study aimed to investigate the effects of two different positions on lower extremity hemodynamics during robot-assisted laparoscopic radical prostatectomy (RARP) for prostate cancer. METHODS: A total of 196 patients who underwent RARP in our hospital from February 2020 to March 2022 were included in this study. Among them, 98 patients who underwent surgery with the Trendelenburg position and split-leg position with calf reverse arch from March 2021 to March 2022 were assigned to the observation group, while 98 patients who underwent surgery with the Trendelenburg position and low lithotomy position from February 2020 to February 2021 were assigned to the control group...
April 20, 2024: BMC Urology
https://read.qxmd.com/read/38641173/diagnosis-and-treatment-of-deep-vein-thrombosis-of-the-lower-and-upper-limbs-2024-recommendations-of-the-thromboembolic-disease-group-of-the-spanish-society-of-internal-medicine
#12
JOURNAL ARTICLE
Aída Gil Díaz, Javier Martín Guerra, Pedro Parra Caballero, Gabriel Puche Palao, Nuria Muñoz Rivas, Nuria Ruiz-Giménez Arrieta
Deep vein thrombosis (DVT) of the limbs is a common disease and causes significant morbidity and mortality. It is frequently the prelude to pulmonary embolism (PE), it can recur in 30% of patients and in 25-40% of cases they can develop post-thrombotic syndrome (PTS), with a significant impact in functional status and quality of life. This document contains the recommendations on the diagnosis and treatment of acute DVT from the Thromboembolic Disease group of the Spanish Society of Internal Medicine (SEMI)...
April 17, 2024: Revista Clínica Espanõla
https://read.qxmd.com/read/38637802/the-interaction-of-platelet-related-factors-with-tumor-cells-promotes-tumor-metastasis
#13
REVIEW
Jie Xue, Jianzhao Deng, Hongwei Qin, Songxia Yan, Zhen Zhao, Lifeng Qin, Jiao Liu, Haiyan Wang
Platelets not only participate in thrombosis and hemostasis but also interact with tumor cells and protect them from mechanical damage caused by hemodynamic shear stress and natural killer cell lysis, thereby promoting their colonization and metastasis to distant organs. Platelets can affect the tumor microenvironment via interactions between platelet-related factors and tumor cells. Metastasis is a key event in cancer-related death and is associated with platelet-related factors in lung, breast, and colorectal cancers...
April 18, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38637207/central-venous-catheter-consideration-in-pediatric-oncology-a-systematic-review-and-meta-analysis-from-the-american-pediatric-surgical-association-cancer-committee
#14
JOURNAL ARTICLE
Emily R Christison-Lagay, Erin G Brown, Jennifer Bruny, Melissa Funaro, Richard D Glick, Roshni Dasgupta, Christa N Grant, Abigail J Engwall-Gill, Timothy B Lautz, David Rothstein, Ashley Walther, Peter F Ehrlich, Jennifer H Aldrink, David Rodeberg, Reto M Baertschiger
BACKGROUND: Tunneled central venous catheters (CVCs) are the cornerstone of modern oncologic practice. Establishing best practices for catheter management in children with cancer is essential to optimize care, but few guidelines exist to guide placement and management. OBJECTIVES: To address four questions: 1) Does catheter composition influence the incidence of complications; 2) Is there a platelet count below which catheter placement poses an increased risk of complications; 3) Is there an absolute neutrophil count (ANC) below which catheter placement poses an increased risk of complications; and 4) Are there best practices for the management of a central line associated bloodstream infection (CLABSI)? METHODS: Data Sources: English language articles in Ovid Medline, PubMed, Embase, Web of Science, and Cochrane Databases...
March 27, 2024: Journal of Pediatric Surgery
https://read.qxmd.com/read/38634194/long-noncoding-rna-small-nucleolar-rna-host-genes-as-prognostic-molecular-biomarkers-in-hepatocellular-carcinoma-a-meta-analysis
#15
REVIEW
Meng Huang, Zhiwen Zhao, Lihua Yang
BACKGROUND: Recently, increasing data have suggested that the lncRNA small nucleolar RNA host genes (SNHGs) were aberrantly expressed in hepatocellular carcinoma (HCC), but the association between the prognosis of HCC and their expression remained unclear. The purpose of this meta-analysis was to determine the prognostic significance of lncRNA SNHGs in HCC. METHODS: We systematically searched Embase, Web of Science, PubMed, and Cochrane Library for eligible articles published up to February 2024...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38633835/clinical-variables-associated-with-major-adverse-cardiac-events-following-radical-cystectomy
#16
JOURNAL ARTICLE
Aaron A Gurayah, Ruben Blachman-Braun, Christopher J Machado, Matthew M Mason, Helen Y Hougen, Ali Mouzannar, Mark L Gonzalgo, Bruno Nahar, Sanoj Punnen, Dipen J Parekh, Chad R Ritch
OBJECTIVES: The objective of this study is to investigate the association between major adverse cardiac events (MACE) and clinical factors of patients undergoing radical cystectomy (RC) for bladder cancer. MATERIALS AND METHODS: A retrospective analysis using the 2015-2020 National Surgical Quality Improvement Program database was performed on patients who underwent RC for bladder cancer. MACE was defined as any report of cerebrovascular accident, myocardial infarction, or thromboembolic events (pulmonary embolism or deep vein thrombosis)...
April 2024: BJUI compass
https://read.qxmd.com/read/38632623/a-tempo-spatial-controllable-microfluidic-shear-stress-generator-for-in-vitro-mimicking-of-the-thrombus
#17
JOURNAL ARTICLE
Zhihang Yu, Yiqun Chen, Jingjing Li, Chang Chen, Huaxiu Lu, Siyuan Chen, Tingting Zhang, Tianruo Guo, Yonggang Zhu, Jing Jin, Sheng Yan, Huaying Chen
Pathological conditions linked to shear stress have been identified in hematological diseases, cardiovascular diseases, and cancer. These conditions often exhibit significantly elevated shear stress levels, surpassing 1000 dyn/cm2 in severely stenotic arteries. Heightened shear stress can induce mechanical harm to endothelial cells, potentially leading to bleeding and fatal consequences. However, current technology still grapples with limitations, including inadequate flexibility in simulating bodily shear stress environments, limited range of shear stress generation, and spatial and temporal adaptability...
April 17, 2024: Journal of Nanobiotechnology
https://read.qxmd.com/read/38632029/-translation-into-french-and-republication-of-home-treatment-for-patients-with-cancer-associated-venous-thromboembolism
#18
REVIEW
Olivier Sanchez, Pierre-Marie Roy, Yoann Gaboreau, Jeannot Schmidt, Farès Moustafa, Asmahane Benmaziane, Antoine Élias, Olivier Espitia, Marie-Antoinette Sevestre, Francis Couturaud, Isabelle Mahé
Patients hospitalised with acute venous thromboembolism (VTE), and notably patients with pulmonary embolism, often remain in hospital for extended periods due to the perceived risk of complications. However, several studies have shown that home treatment of selected patients is feasible and safe, with a low incidence of adverse events. This may offer clear benefits for patients' quality of life, hospital planning and cost to the health service. Nonetheless, there is a need for a VTE risk-stratification tool specifically addressing prognosis in patients with cancer...
April 16, 2024: La Revue de Médecine Interne
https://read.qxmd.com/read/38628350/inpatient-outcomes-for-lung-cancer-patients-presenting-with-superior-vena-cava-thrombosis
#19
JOURNAL ARTICLE
Jay Vakil, Ekrem Turk, Maria Cristina Cuartas-Mesa, Vaishali Deenadayalan, Kunnal Batra
BACKGROUND: A specific cause of superior vena cava (SVC) syndrome, SVC thrombosis, is a rare but known complication in cancer patients. Early identification and management of SVC thrombosis in lung cancer patients may lead to improved patient outcomes and a reduction in healthcare costs. METHODS: We studied the racial and socioeconomic differences, length of stay, total hospital charges, and all-cause mortality outcomes in patients with lung cancer with and without SVC thrombosis using data from the National Inpatient Sample...
2024: Proceedings of the Baylor University Medical Center
https://read.qxmd.com/read/38626964/predictive-factors-of-clot-propagation-in-patients-with-superficial-venous-thrombosis-towards-deep-venous-thrombosis-and-pulmonary-embolism-a-systematic-review-and-meta-analysis
#20
JOURNAL ARTICLE
Florien Sophie-Anne van Royen, Maarten van Smeden, Sander van Doorn, Frans H Rutten, Geert-Jan Geersing
OBJECTIVE: A subset of patients with superficial venous thrombosis (SVT) experiences clot propagation towards deep venous thrombosis (DVT) and/or pulmonary embolism (PE). The aim of this systematic review is to identify all clinically relevant cross-sectional and prognostic factors for predicting thrombotic complications in patients with SVT. DESIGN: Systematic review. DATA SOURCES: PubMed/MEDLINE and Embase were systematically searched until 3 March 2023...
April 16, 2024: BMJ Open
keyword
keyword
28916
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.